Related Experiment Video
Updated: Mar 1, 2026
09:32
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.7K
Atopic dermatitis phenotypes and the need for personalized medicine
Beatriz Cabanillas1, Ann-Christin Brehler, Natalija Novak
1Department of Dermatology and Allergy, University of Bonn, Bonn, Germany.
Current Opinion in Allergy and Clinical Immunology
|June 6, 2017
Summary
New therapies for atopic dermatitis (AD) are emerging, targeting specific molecular mechanisms. This approach promises personalized treatments by stratifying AD phenotypes for better efficacy.
Area of Science:
- Dermatology
- Immunology
- Molecular Biology
Background:
- Atopic dermatitis (AD) is a complex inflammatory skin condition with significant unmet treatment needs.
- Current standard treatments for AD lack personalization and do not address individual disease pathogenesis.
Purpose of the Study:
- To review recent advancements in therapies targeting the molecular mechanisms of atopic dermatitis.
- To highlight the potential of phenotype-specific treatments for individualized patient care.
Main Methods:
- Literature review of recent developments in atopic dermatitis therapies.
- Analysis of molecular targets and their role in AD pathophysiology.
Main Results:
- Advances in understanding AD molecular basis enable phenotype stratification.
- New therapies aim to modulate specific inflammatory pathways for targeted treatment.
- Investigational therapies focus on personalized, molecule-specific approaches to AD.
Conclusions:
- Targeted, phenotype-specific therapies offer a promising new era for individualized atopic dermatitis treatment.
- Personalized medicine approaches are crucial to address the unmet need for effective and well-tolerated AD therapies.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
65
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
65
01:24Dosage Regimen: Individualization
232
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
232
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
56
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
01:29Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
01:29Pharmacogenetics and Pharmacogenomics: Overview
74
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
74
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K